Through differential expression analysis, it was found that the expression of most m6A regulators was altered between the normal group and ischemic stroke patients; IGF2BP2, IGF2BP1, and YTHDF2 expression was significantly upregulated in IS samples, while ELAVL1, LRPPRC, METTL3, ALKBH5, CBLL1, and METTL14 expression was significantly downregulated in IS samples. This evidence concerns the gene METTL14 and ischemic stroke.